• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey.中国社区获得性肺炎住院青少年及成人的疾病特征与管理:一项回顾性多中心调查
BMJ Open. 2018 Feb 15;8(2):e018709. doi: 10.1136/bmjopen-2017-018709.
2
Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.中国住院低风险社区获得性肺炎患者护理中的成本节约潜力。
Value Health. 2009 Jan-Feb;12(1):40-6. doi: 10.1111/j.1524-4733.2008.00410.x. Epub 2008 Jul 10.
3
Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.社区获得性肺炎住院患者的资源使用及护理成本:遵循美国传染病学会指南的影响
Pharmacoeconomics. 2004;22(11):751-7. doi: 10.2165/00019053-200422110-00005.
4
Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.荷兰老年人社区获得性肺炎的住院费用:一项观察性研究。
BMC Infect Dis. 2016 Sep 2;16(1):466. doi: 10.1186/s12879-016-1783-9.
5
The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.社区获得性肺炎(CAP)住院患者的年度经济负担:一项回顾性美国队列研究。
Curr Med Res Opin. 2020 Jan;36(1):151-160. doi: 10.1080/03007995.2019.1675149. Epub 2019 Oct 17.
6
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis.社区获得性肺炎住院的微生物病因、结局和费用:一项观察性分析。
BMC Infect Dis. 2014 Jun 17;14:335. doi: 10.1186/1471-2334-14-335.
7
Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.达到临床稳定后的住院时间决定了与成人社区获得性肺炎相关的医院成本。
Scand J Infect Dis. 2013 Mar;45(3):219-26. doi: 10.3109/00365548.2012.726737. Epub 2012 Oct 31.
8
Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital.测量铜绿假单胞菌肺炎的住院费用:来自德国教学医院的方法学和结果。
BMC Infect Dis. 2019 Dec 3;19(1):1028. doi: 10.1186/s12879-019-4660-5.
9
Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.社区获得性肺炎:住院医疗护理的经济学与临床严重程度对比
J Bras Pneumol. 2015 Jan-Feb;41(1):48-57. doi: 10.1590/S1806-37132015000100007.
10
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.社区获得性肺炎住院患者的发病率、直接费用及住院时长:一项全国性回顾性索赔数据库分析
Vaccine. 2015 Jun 22;33(28):3193-9. doi: 10.1016/j.vaccine.2015.05.001. Epub 2015 May 14.

引用本文的文献

1
Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.菲律宾确诊 COVID-19 感染患者的抗菌药物使用情况:一项横断面研究。
Western Pac Surveill Response J. 2023 Jun 24;14(2):1-8. doi: 10.5365/wpsar.2023.14.2.999. eCollection 2023 Apr-Jun.
2
Application of Different Sampling Methods Combined with Metagenomic Next-Generation Sequencing to Detect Pathogens in Children with Severe Pneumonia on Mechanical Ventilation.不同采样方法联合宏基因组下一代测序在机械通气的重症肺炎儿童中检测病原体的应用
Infect Drug Resist. 2023 Jul 12;16:4545-4553. doi: 10.2147/IDR.S418339. eCollection 2023.
3
Overuse of medications in low- and middle-income countries: a scoping review.中低收入国家药物的过度使用:范围综述。
Bull World Health Organ. 2023 Jan 1;101(1):36-61D. doi: 10.2471/BLT.22.288293. Epub 2022 Oct 31.
4
Chest physiotherapy for pneumonia in adults.成人肺炎的胸部物理治疗。
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD006338. doi: 10.1002/14651858.CD006338.pub4.
5
Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis.奈诺沙星、莫西沙星和左氧氟沙星治疗可能合并肺结核的早期社区获得性肺炎的经济学评价。
Int J Environ Res Public Health. 2022 Apr 15;19(8):4816. doi: 10.3390/ijerph19084816.
6
Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial.在中国社区获得性肺炎住院患者中头孢洛林酯的疗效和安全性:一项国际3期随机对照试验的亚组分析
Infect Drug Resist. 2022 Feb 23;15:605-617. doi: 10.2147/IDR.S342558. eCollection 2022.
7
Flu-IV score: a predictive tool for assessing the risk of invasive mechanical ventilation in patients with influenza-related pneumonia.流感-IV 评分:一种评估流感相关性肺炎患者进行有创机械通气风险的预测工具。
BMC Pulm Med. 2022 Jan 29;22(1):47. doi: 10.1186/s12890-022-01833-2.
8
A Retrospective Paired Comparison Between Untargeted Next Generation Sequencing and Conventional Microbiology Tests With Wisely Chosen Metagenomic Sequencing Positive Criteria.基于明智选择的宏基因组测序阳性标准,对非靶向下一代测序与传统微生物检测进行回顾性配对比较。
Front Med (Lausanne). 2021 Oct 6;8:686247. doi: 10.3389/fmed.2021.686247. eCollection 2021.
9
Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community acquired pneumonia.急性肾损伤对中国社区获得性肺炎患者住院结局的影响。
BMC Pulm Med. 2021 May 1;21(1):143. doi: 10.1186/s12890-021-01511-9.
10
Complications of Cardiovascular Events in Patients Hospitalized with Influenza-Related Pneumonia.因流感相关肺炎住院患者的心血管事件并发症
Infect Drug Resist. 2021 Apr 9;14:1363-1373. doi: 10.2147/IDR.S305509. eCollection 2021.

本文引用的文献

1
Application of real-time quantitative polymerase chain reaction assay to detect in patients of community-acquired pneumonia in a tertiary care hospital.实时定量聚合酶链反应检测法在一家三级医院社区获得性肺炎患者中的应用。
Indian J Med Microbiol. 2016 Oct-Dec;34(4):539-543. doi: 10.4103/0255-0857.195353.
2
The FDA Revises Boxed Warning For Fluoroquinolones-Again.美国食品药品监督管理局再次修订氟喹诺酮类药物的黑框警告。
Am J Nurs. 2016 Sep;116(9):22-3. doi: 10.1097/01.NAJ.0000494691.55746.90.
3
[Guidelines for the diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition)].《中国成人社区获得性肺炎诊断和治疗指南(2016年版)》
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Apr 12;39(4):241-2. doi: 10.3760/cma.j.issn.1001-0939.2016.04.001.
4
FDA and the safe and appropriate antibiotic use of fluoroquinolones.美国食品药品监督管理局与氟喹诺酮类药物的安全合理使用
Lancet Infect Dis. 2016 Mar;16(3):e11-2. doi: 10.1016/S1473-3099(16)00051-7.
5
Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years.医疗保健相关肺炎:临床特征及10年回顾性分析
Chin Med J (Engl). 2015 Oct 20;128(20):2707-13. doi: 10.4103/0366-6999.167294.
6
Moxifloxacin Use and Its Association on the Diagnosis of Pulmonary Tuberculosis in An Inner City Emergency Department.莫西沙星的使用及其与市中心急诊科肺结核诊断的关联。
J Emerg Med. 2016 Mar;50(3):371-5. doi: 10.1016/j.jemermed.2015.07.044. Epub 2015 Sep 26.
7
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.美国成年人中需要住院治疗的社区获得性肺炎
N Engl J Med. 2015 Jul 30;373(5):415-27. doi: 10.1056/NEJMoa1500245. Epub 2015 Jul 14.
8
Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).使用经典二线药物(左氧氟沙星和阿米卡星)的耐多药结核病临床分离株中的广泛耐药和准广泛耐药结核病
J Coll Physicians Surg Pak. 2015 May;25(5):337-41.
9
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.社区获得性肺炎住院患者的发病率、直接费用及住院时长:一项全国性回顾性索赔数据库分析
Vaccine. 2015 Jun 22;33(28):3193-9. doi: 10.1016/j.vaccine.2015.05.001. Epub 2015 May 14.
10
Development of a risk-adjusted in-hospital mortality prediction model for community-acquired pneumonia: a retrospective analysis using a Japanese administrative database.开发一种用于社区获得性肺炎的风险调整院内死亡率预测模型:使用日本行政数据库的回顾性分析。
BMC Pulm Med. 2014 Dec 16;14:203. doi: 10.1186/1471-2466-14-203.

中国社区获得性肺炎住院青少年及成人的疾病特征与管理:一项回顾性多中心调查

Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey.

作者信息

Chen Liang, Zhou Fei, Li Hui, Xing Xiqian, Han Xiudi, Wang Yiming, Zhang Chunxiao, Suo Lijun, Wang Jingxiang, Yu Guohua, Wang Guangqiang, Yao Xuexin, Yu Hongxia, Wang Lei, Liu Meng, Xue Chunxue, Liu Bo, Zhu Xiaoli, Li Yanli, Xiao Ying, Cui Xiaojing, Li Lijuan, Uyeki Timothy M, Wang Chen, Cao Bin

机构信息

Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Department of Infectious Disease, 4th Medical College of Peking University, Beijing Jishuitan Hospital, Beijing, China.

出版信息

BMJ Open. 2018 Feb 15;8(2):e018709. doi: 10.1136/bmjopen-2017-018709.

DOI:10.1136/bmjopen-2017-018709
PMID:29449294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5829872/
Abstract

OBJECTIVES

To describe the clinical characteristics and management of patients hospitalised with community-acquired pneumonia (CAP) in China.

DESIGN

This was a multicentre, retrospective, observational study.

SETTING

13 teaching hospitals in northern, central and southern China from 1 January 2014 to 31 December 2014 PARTICIPANTS: Information on hospitalised patients aged ≥14 years with radiographically confirmed pneumonia with illness onset in the community was collected using standard case report forms.

PRIMARY AND SECONDARY OUTCOME MEASURES

Resource use for CAP management.

RESULTS

Of 14 793 patients screened, 5828 with radiographically confirmed CAP were included in the final analysis. Low mortality risk patients with a CURB-65 score 0-1 and Pneumonia Severity Index risk class I-II accounted for 81.2% (4434/5594) and 56.4% (2034/3609) patients, respectively. 21.7% (1111/5130) patients had already achieved clinical stability on admission. A definite or probable pathogen was identified only in 12.7% (738/5828) patients. 40.9% (1575/3852) patients without pseudomonal infection risk factors received antimicrobial overtreatment regimens. The median duration between clinical stability to discharge was 5.0 days with 30-day mortality of 4.2%.

CONCLUSIONS

These data demonstrated the overuse of health resources in CAP management, indicating that there is potential for improvement and substantial savings to healthcare systems in China.

TRIAL REGISTRATION NUMBER

NCT02489578; Results.

摘要

目的

描述中国社区获得性肺炎(CAP)住院患者的临床特征及管理情况。

设计

这是一项多中心、回顾性观察研究。

地点

2014年1月1日至2014年12月31日期间,中国北方、中部和南部的13家教学医院。

参与者

使用标准病例报告表收集年龄≥14岁、影像学确诊为社区发病肺炎的住院患者信息。

主要和次要观察指标

CAP管理的资源使用情况。

结果

在筛查的14793例患者中,5828例影像学确诊为CAP的患者纳入最终分析。CURB-65评分0-1分的低死亡风险患者和肺炎严重程度指数风险等级I-II级的患者分别占81.2%(4434/5594)和56.4%(2034/3609)。21.7%(1111/5130)的患者入院时已达到临床稳定。仅在12.7%(738/5828)的患者中确定了明确或可能的病原体。40.9%(1575/3852)无假单胞菌感染风险因素的患者接受了抗菌药物过度治疗方案。从临床稳定到出院的中位时间为5.0天,30天死亡率为4.2%。

结论

这些数据表明CAP管理中卫生资源的过度使用,表明中国医疗系统有改善的潜力和可观的节省空间。

试验注册号

NCT02489578;结果。